Cargando…
RSK1 protects P-glycoprotein/ABCB1 against ubiquitin–proteasomal degradation by downregulating the ubiquitin-conjugating enzyme E2 R1
P-glycoprotein (P-gp) is a critical determinant of multidrug resistance in cancer. We previously reported that MAPK inhibition downregulates P-gp expression and that P-gp undergoes ubiquitin–proteasomal degradation regulated by UBE2R1 and SCF(Fbx15). Here, we investigated the crosstalk between MAPK...
Autores principales: | Katayama, Kazuhiro, Fujiwara, Chiaki, Noguchi, Kohji, Sugimoto, Yoshikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081560/ https://www.ncbi.nlm.nih.gov/pubmed/27786305 http://dx.doi.org/10.1038/srep36134 |
Ejemplares similares
-
Conjugation of the Ubiquitin Activating Enzyme UBE1 with the Ubiquitin-Like Modifier FAT10 Targets It for Proteasomal Degradation
por: Bialas, Johanna, et al.
Publicado: (2015) -
Upregulation of cellular glutathione levels in human ABCB5- and murine Abcb5-transfected cells
por: Kondo, Shingo, et al.
Publicado: (2015) -
The Ubiquitin Conjugating Enzyme: An Important Ubiquitin Transfer Platform in Ubiquitin-Proteasome System
por: Liu, Weigang, et al.
Publicado: (2020) -
Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targets
por: Bedford, Lynn, et al.
Publicado: (2010) -
Attenuation of the ubiquitin conjugate DNA damage signal by the proteasomal DUB POH1
por: Morris, Joanna R.
Publicado: (2012)